Concepts and Methods in Infectious Disease Surveillance. (Record no. 40433)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 11142nam a22004933i 4500 |
001 - CONTROL NUMBER | |
control field | EBC1776086 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | MiAaPQ |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20240729123030.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m o d | |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr cnu|||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 240724s2023 xx o ||||0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781118928639 |
Qualifying information | (electronic bk.) |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (MiAaPQ)EBC1776086 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (Au-PeEL)EBL1776086 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (CaPaEBR)ebr10925520 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (CaONFJC)MIL640765 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)890071970 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | MiAaPQ |
Language of cataloging | eng |
Description conventions | rda |
-- | pn |
Transcribing agency | MiAaPQ |
Modifying agency | MiAaPQ |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RA643 -- .C663 2015eb |
082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.9 |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | M'ikanatha, Nkuchia M. |
245 10 - TITLE STATEMENT | |
Title | Concepts and Methods in Infectious Disease Surveillance. |
250 ## - EDITION STATEMENT | |
Edition statement | 1st ed. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Place of production, publication, distribution, manufacture | Newark : |
Name of producer, publisher, distributor, manufacturer | John Wiley & Sons, Incorporated, |
Date of production, publication, distribution, manufacture, or copyright notice | 2023. |
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | ©2013. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource (299 pages) |
336 ## - CONTENT TYPE | |
Content type term | text |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type term | computer |
Media type code | c |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier type term | online resource |
Carrier type code | cr |
Source | rdacarrier |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Cover -- Title page -- Copyright page -- Contents -- List of contributors -- Foreword -- Preface -- Acknowledgments -- Acronyms and abbreviations -- SECTION I: Introduction to infectious disease surveillance -- CHAPTER 1: Surveillance as a foundation for infectious disease prevention and control -- Background and rationale -- Definitions -- Public health disease surveillance -- Newer types of surveillance -- Historical development of infectious disease surveillance -- Conclusion -- References -- CHAPTER 2: The legal basis for public health surveillance -- Introduction -- The roles of state and federal laws in infectious disease surveillance -- Privacy Act of 1974 -- HIPAA Privacy Rule -- Public Health Service Act -- Family Educational Rights and Privacy Act -- Freedom of Information Act -- State laws -- The limits of the law -- Examples from recent infectious disease outbreaks -- Key summary points for public health practitioners -- References -- CHAPTER 3: National, state, and local public health surveillance systems -- Organization and roles of public health infectious disease surveillance infrastructure in the United States and steps in the surveillance process -- State and local public health organization and roles -- Surveillance process roles and responsibilities -- Analysis and use of surveillance data -- State reportable and national notifiable condition surveillance -- Methods used for surveillance -- Active versus passive surveillance -- Laboratory-based surveillance -- Other surveillance -- Resources -- Electronic methods and other recent innovations -- Integrated and interoperable surveillance systems -- Electronic laboratory results reporting -- Electronic public health case reporting -- Standards-based case notification to CDC -- Conclusion -- References. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | CHAPTER 4: Quarantine and the role of surveillance in nineteenth-century public health -- Overview -- Introduction -- Debating quarantine and yellow fever, 1850-1880 -- Summary -- References -- SECTION II: Specific surveillance systems -- CHAPTER 5: Surveillance for vaccine-preventable diseases and immunization -- Introduction -- Step one: understanding the background: burden and risk factors of VPD illness and transmission processes of the target pathogen -- Step two: understanding the vaccines -- Step three: identify the data sources for disease surveillance and their availability, strengths, and weaknesses -- Step four: assessing the performance: conducting post-marketing VPD surveillance and assessing vaccine effectiveness -- Step five: preparing for the unexpected and continuing the evaluation -- What if the sample size is too small to detect an uncommon adverse event possibly associated with the vaccine? -- What are the effects of a population-wide vaccination program on individuals who are not vaccinated? -- What is the impact of inclusion of a substance that was not originally intended to be in the vaccine? -- Conclusion -- References -- CHAPTER 6: Surveillance for seasonal and novel influenza viruses -- Introduction -- Clinical, epidemiological, and virological characteristics and implications for surveillance -- Possible surveillance schemes -- Virologic surveillance -- Outpatient sentinel surveillance -- Integration of clinical, epidemiological, and virological surveillance -- Use of qualitative indicators -- Indirect indicators of influenza circulation -- Surveillance of severe influenza cases -- Animal influenza surveillance -- Surveillance during a pandemic -- Monitoring of vaccination programs -- Vaccination coverage monitoring -- Vaccination safety monitoring -- Vaccination effectiveness monitoring -- Conclusions -- Acknowledgements. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | References -- CHAPTER 7: Population-based surveillance for bacterial infections of public health importance -- Introduction -- History of ABCs -- ABCs sites and infrastructure -- ABCs methods -- Examples of use of ABCs data for specific pathogens -- Antimicrobial chemoprophylaxis to prevent early onset GBS -- Invasive pneumococcal disease surveillance and vaccine effectiveness studies -- Epidemiology and molecular surveillance of meningococcal disease -- Challenges and opportunities -- Conclusions -- Acknowledgements -- References -- CHAPTER 8: Surveillance for foodborne diseases -- Introduction -- Objectives of foodborne-disease surveillance -- Methods for foodborne-disease surveillance -- Notifiable diseases -- Laboratory-based surveillance and subtyping -- Surveillance at sentinel sites -- Hospital discharge records and death registration -- Foodborne-disease complaint systems -- Outbreak reports -- Advances in the detection of foodborne outbreaks in the United States -- Conclusions -- References -- CHAPTER 9: Surveillance of healthcare-associated infections -- Introduction -- The purpose and value of HAI surveillance -- Concept of comparable rates -- National Healthcare Safety Network -- Questions to address before instituting HAI surveillance -- Limitations of rates for interhospital comparison -- Lack of severity of illness adjustment -- Difficulties of HAI surveillance in the outpatient and home healthcare settings -- The role of microbiologic surveillance in the control and prevention of HAI -- Conclusion -- References -- CHAPTER 10: Surveillance for zoonotic diseases -- Introduction -- Transmission -- Public health risk -- Emerging zoonotic disease and global impact -- Zoonotic disease surveillance -- Approaches to surveillance -- Integrated approach to surveillance in humans and animals -- Novel zoonotic disease surveillance systems. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Bioterrorism -- Stakeholders -- National surveillance and reporting -- Global surveillance and reporting -- Examples of surveillance for zoonotic diseases -- Rabies -- Brucellosis -- Plague -- Conclusions -- References -- CHAPTER 11: Surveillance of viral hepatitis infections -- Introduction -- Clinical background of viral hepatitis -- Epidemiology of viral hepatitis -- Purpose of viral hepatitis surveillance -- Surveillance methods -- Acute viral hepatitis -- Chronic HBV and HCV infections -- Progress in viral hepatitis surveillance -- Surveillance Mechanisms -- Conclusions -- References -- CHAPTER 12: Surveillance for sexually transmitted diseases -- Introduction -- Health impact of STDs -- Objectives of STD surveillance -- Challenges in STD surveillance -- Strategies for STD surveillance -- Case reporting -- Sentinel surveillance -- Opportunistic surveillance -- Population-based studies -- Conclusion -- References -- CHAPTER 13: Surveillance for HIV in the United States -- Introduction: biology and natural history of HIV -- Surveillance implications of the unique epidemiology of HIV -- The impact of stigma on the development of HIV surveillance systems -- Surveillance methods for HIV -- Case identification -- Data sources and case-finding -- Electronic laboratory reporting -- Surveillance activities specific to HIV -- Data sources and data flow -- Record linkage and registry matches -- Evaluation of HIV surveillance programs and performance standards -- Data management -- Role of information technology staff and data managers -- Training and technical assistance for HIV surveillance staff -- Security and confidentiality -- Uses of HIV surveillance data -- Expanded surveillance -- Incidence surveillance -- Molecular HIV surveillance -- Behavioral surveillance -- Clinical surveillance -- Conclusion -- Acknowledgments -- References. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | CHAPTER 14: Public health surveillance for tuberculosis -- Introduction -- Laboratory detection of Mycobacterium tuberculosis -- TB case verification criteria -- History of tuberculosis surveillance in the United States -- Current tuberculosis reporting in the United States -- Tuberculosis surveillance data reporting and publication -- Quality, completeness, and timeliness of reporting -- References -- SECTION III: Methods used in surveillance and data analysis -- CHAPTER 15: Analysis and interpretation of surveillance data -- Introduction -- Challenge 1: understand the purpose and context of surveillance systems -- Challenge 2: identify baselines and recognize deviations -- Standardize observations -- Ensure precise case definitions -- Analyze denominator data -- Ensure systematic presentation -- Compare observations over time -- Use visual display of data -- Analyze aberrations -- Employ molecular analysis -- Challenges 3, 4, and 5: interpretation of meaning, significance, and degree of certainty -- Characterize person, place, and time -- Define epidemic thresholds -- Ascertain degree of certainty -- Challenge 6: communicate for public health action -- Evolving approaches to disease detection, analysis, and interpretation -- Conclusions -- Acknowledgments -- References -- CHAPTER 16: Global surveillance for emerging infectious diseases -- Introduction -- Overview of surveillance -- Definition of terms -- Architecture of systems for global surveillance and outbreak response -- Key developments in approaches to global surveillance -- 2005 revision to International Health Regulations -- Increasing interest in surveillance for security purposes -- Increased adoption of syndromic surveillance systems -- Increased availability of electronic health information -- Development of surveillance efforts to predict future disease threats -- Remaining challenges. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Inadequate laboratory capabilities and clinical expertise to detect diseases. |
588 ## - SOURCE OF DESCRIPTION NOTE | |
Source of description note | Description based on publisher supplied metadata and other sources. |
590 ## - LOCAL NOTE (RLIN) | |
Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Communicable diseases -- Prevention. |
655 #4 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Iskander, John. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Relationship information | Print version: |
Main entry heading | M'ikanatha, Nkuchia M. |
Title | Concepts and Methods in Infectious Disease Surveillance |
Place, publisher, and date of publication | Newark : John Wiley & Sons, Incorporated,c2023 |
797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=1776086">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=1776086</a> |
Public note | Click to View |
No items available.